kc 764 has been researched along with thromboxane a2 in 1 studies
| Studies (kc 764) | Trials (kc 764) | Recent Studies (post-2010) (kc 764) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 9 | 1 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohkubo, H; Ohmuro, S; Sasahara, T; Taga, F; Uchida, H | 1 |
1 other study(ies) available for kc 764 and thromboxane a2
| Article | Year |
|---|---|
Antiplatelet effects of 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine in relation to its disposition in rats, rabbits and dogs.
Topics: Animals; Aspirin; Bridged Bicyclo Compounds; Dogs; Epoprostenol; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicotinic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Inbred Strains; Species Specificity; Thromboxane A2; Tissue Distribution | 1992 |